Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Zika discourse in the Americas: A multilingual topic analysis of Twitter.

Pruss D, Fujinuma Y, Daughton AR, Paul MJ, Arnot B, Albers Szafir D, Boyd-Graber J.

PLoS One. 2019 May 23;14(5):e0216922. doi: 10.1371/journal.pone.0216922. eCollection 2019.

2.

Corrigendum to: Breast cancer brain metastases show increased levels of genomic aberration-based homologous recombination deficiency scores relative to their corresponding primary tumors.

Diossy M, Reiniger L, Sztupinszki Z, Krzystanek M, Timms KM, Neff C, Solimeno C, Pruss D, Eklund AC, Tóth E, Kiss O, Rusz O, Cserni G, Zombori T, Székely B, Kulka J, Tímár J, Csabai I, Szallasi Z.

Ann Oncol. 2019 Mar 30. pii: mdz081. doi: 10.1093/annonc/mdz081. [Epub ahead of print] No abstract available.

PMID:
30929001
3.

Breast cancer brain metastases show increased levels of genomic aberration-based homologous recombination deficiency scores relative to their corresponding primary tumors.

Diossy M, Reiniger L, Sztupinszki Z, Krzystanek M, Timms KM, Neff C, Solimeno C, Pruss D, Eklund AC, Tóth E, Kiss O, Rusz O, Cserni G, Zombori T, Székely B, Tímár J, Csabai I, Szallasi Z.

Ann Oncol. 2018 Sep 1;29(9):1948-1954. doi: 10.1093/annonc/mdy216.

4.

Risk alleles of genes with monoallelic expression are enriched in gain-of-function variants and depleted in loss-of-function variants for neurodevelopmental disorders.

Savova V, Vinogradova S, Pruss D, Gimelbrant AA, Weiss LA.

Mol Psychiatry. 2017 Dec;22(12):1785-1794. doi: 10.1038/mp.2017.13. Epub 2017 Mar 7.

5.

AluY-mediated germline deletion, duplication and somatic stem cell reversion in UBE2T defines a new subtype of Fanconi anemia.

Virts EL, Jankowska A, Mackay C, Glaas MF, Wiek C, Kelich SL, Lottmann N, Kennedy FM, Marchal C, Lehnert E, Scharf RE, Dufour C, Lanciotti M, Farruggia P, Santoro A, Savasan S, Scheckenbach K, Schipper J, Wagenmann M, Lewis T, Leffak M, Farlow JL, Foroud TM, Honisch E, Niederacher D, Chakraborty SC, Vance GH, Pruss D, Timms KM, Lanchbury JS, Alpi AF, Hanenberg H.

Hum Mol Genet. 2015 Sep 15;24(18):5093-108. doi: 10.1093/hmg/ddv227. Epub 2015 Jun 17.

6.

Exceptions to the rule: case studies in the prediction of pathogenicity for genetic variants in hereditary cancer genes.

Rosenthal ET, Bowles KR, Pruss D, van Kan A, Vail PJ, McElroy H, Wenstrup RJ.

Clin Genet. 2015 Dec;88(6):533-41. doi: 10.1111/cge.12560. Epub 2015 Feb 11.

PMID:
25639900
7.

Development and validation of a new algorithm for the reclassification of genetic variants identified in the BRCA1 and BRCA2 genes.

Pruss D, Morris B, Hughes E, Eggington JM, Esterling L, Robinson BS, van Kan A, Fernandes PH, Roa BB, Gutin A, Wenstrup RJ, Bowles KR.

Breast Cancer Res Treat. 2014 Aug;147(1):119-32. doi: 10.1007/s10549-014-3065-9. Epub 2014 Aug 2.

PMID:
25085752
8.

A comprehensive laboratory-based program for classification of variants of uncertain significance in hereditary cancer genes.

Eggington JM, Bowles KR, Moyes K, Manley S, Esterling L, Sizemore S, Rosenthal E, Theisen A, Saam J, Arnell C, Pruss D, Bennett J, Burbidge LA, Roa B, Wenstrup RJ.

Clin Genet. 2014 Sep;86(3):229-37. doi: 10.1111/cge.12315. Epub 2013 Dec 20.

PMID:
24304220
9.

Functional evaluation of BRCA2 variants mapping to the PALB2-binding and C-terminal DNA-binding domains using a mouse ES cell-based assay.

Biswas K, Das R, Eggington JM, Qiao H, North SL, Stauffer S, Burkett SS, Martin BK, Southon E, Sizemore SC, Pruss D, Bowles KR, Roa BB, Hunter N, Tessarollo L, Wenstrup RJ, Byrd RA, Sharan SK.

Hum Mol Genet. 2012 Sep 15;21(18):3993-4006. doi: 10.1093/hmg/dds222. Epub 2012 Jun 7.

10.

The genome of the domesticated apple (Malus × domestica Borkh.).

Velasco R, Zharkikh A, Affourtit J, Dhingra A, Cestaro A, Kalyanaraman A, Fontana P, Bhatnagar SK, Troggio M, Pruss D, Salvi S, Pindo M, Baldi P, Castelletti S, Cavaiuolo M, Coppola G, Costa F, Cova V, Dal Ri A, Goremykin V, Komjanc M, Longhi S, Magnago P, Malacarne G, Malnoy M, Micheletti D, Moretto M, Perazzolli M, Si-Ammour A, Vezzulli S, Zini E, Eldredge G, Fitzgerald LM, Gutin N, Lanchbury J, Macalma T, Mitchell JT, Reid J, Wardell B, Kodira C, Chen Z, Desany B, Niazi F, Palmer M, Koepke T, Jiwan D, Schaeffer S, Krishnan V, Wu C, Chu VT, King ST, Vick J, Tao Q, Mraz A, Stormo A, Stormo K, Bogden R, Ederle D, Stella A, Vecchietti A, Kater MM, Masiero S, Lasserre P, Lespinasse Y, Allan AC, Bus V, Chagné D, Crowhurst RN, Gleave AP, Lavezzo E, Fawcett JA, Proost S, Rouzé P, Sterck L, Toppo S, Lazzari B, Hellens RP, Durel CE, Gutin A, Bumgarner RE, Gardiner SE, Skolnick M, Egholm M, Van de Peer Y, Salamini F, Viola R.

Nat Genet. 2010 Oct;42(10):833-9. doi: 10.1038/ng.654. Epub 2010 Aug 29.

PMID:
20802477
11.

Somatic mutations in BRCA1 and BRCA2 could expand the number of patients that benefit from poly (ADP ribose) polymerase inhibitors in ovarian cancer.

Hennessy BT, Timms KM, Carey MS, Gutin A, Meyer LA, Flake DD 2nd, Abkevich V, Potter J, Pruss D, Glenn P, Li Y, Li J, Gonzalez-Angulo AM, McCune KS, Markman M, Broaddus RR, Lanchbury JS, Lu KH, Mills GB.

J Clin Oncol. 2010 Aug 1;28(22):3570-6. doi: 10.1200/JCO.2009.27.2997. Epub 2010 Jul 6.

12.

Retrospective analysis of community pharmacists' recommendations in the North Carolina Medicaid medication therapy management program.

Michaels NM, Jenkins GF, Pruss DL, Heidrick JE, Ferreri SP.

J Am Pharm Assoc (2003). 2010 May-Jun;50(3):347-53. doi: 10.1331/JAPhA.2010.09021.

PMID:
20452907
13.

BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer.

Hall MJ, Reid JE, Burbidge LA, Pruss D, Deffenbaugh AM, Frye C, Wenstrup RJ, Ward BE, Scholl TA, Noll WW.

Cancer. 2009 May 15;115(10):2222-33. doi: 10.1002/cncr.24200. Erratum in: Cancer. 2009 Jun 15;115(12):2804.

14.

Sequencing and assembly of highly heterozygous genome of Vitis vinifera L. cv Pinot Noir: problems and solutions.

Zharkikh A, Troggio M, Pruss D, Cestaro A, Eldrdge G, Pindo M, Mitchell JT, Vezzulli S, Bhatnagar S, Fontana P, Viola R, Gutin A, Salamini F, Skolnick M, Velasco R.

J Biotechnol. 2008 Aug 31;136(1-2):38-43. doi: 10.1016/j.jbiotec.2008.04.013. Epub 2008 May 3.

PMID:
18538432
15.

Functional assays for classification of BRCA2 variants of uncertain significance.

Farrugia DJ, Agarwal MK, Pankratz VS, Deffenbaugh AM, Pruss D, Frye C, Wadum L, Johnson K, Mentlick J, Tavtigian SV, Goldgar DE, Couch FJ.

Cancer Res. 2008 May 1;68(9):3523-31. doi: 10.1158/0008-5472.CAN-07-1587.

16.

A high quality draft consensus sequence of the genome of a heterozygous grapevine variety.

Velasco R, Zharkikh A, Troggio M, Cartwright DA, Cestaro A, Pruss D, Pindo M, Fitzgerald LM, Vezzulli S, Reid J, Malacarne G, Iliev D, Coppola G, Wardell B, Micheletti D, Macalma T, Facci M, Mitchell JT, Perazzolli M, Eldredge G, Gatto P, Oyzerski R, Moretto M, Gutin N, Stefanini M, Chen Y, Segala C, Davenport C, Demattè L, Mraz A, Battilana J, Stormo K, Costa F, Tao Q, Si-Ammour A, Harkins T, Lackey A, Perbost C, Taillon B, Stella A, Solovyev V, Fawcett JA, Sterck L, Vandepoele K, Grando SM, Toppo S, Moser C, Lanchbury J, Bogden R, Skolnick M, Sgaramella V, Bhatnagar SK, Fontana P, Gutin A, Van de Peer Y, Salamini F, Viola R.

PLoS One. 2007 Dec 19;2(12):e1326.

17.

A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes.

Easton DF, Deffenbaugh AM, Pruss D, Frye C, Wenstrup RJ, Allen-Brady K, Tavtigian SV, Monteiro AN, Iversen ES, Couch FJ, Goldgar DE.

Am J Hum Genet. 2007 Nov;81(5):873-83. Epub 2007 Sep 6.

18.

Villous adenoma after appendiceal uterine transplantation.

Edden Y, Shussman N, Amir G, Pruss D, Rojansky N, Pikarsky AJ.

Int J Gynaecol Obstet. 2008 Jan;100(1):83-4. Epub 2007 Sep 21. No abstract available.

PMID:
17888436
19.

Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance.

Chenevix-Trench G, Healey S, Lakhani S, Waring P, Cummings M, Brinkworth R, Deffenbaugh AM, Burbidge LA, Pruss D, Judkins T, Scholl T, Bekessy A, Marsh A, Lovelock P, Wong M, Tesoriero A, Renard H, Southey M, Hopper JL, Yannoukakos K, Brown M, Easton D, Tavtigian SV, Goldgar D, Spurdle AB; kConFab Investigators.

Cancer Res. 2006 Feb 15;66(4):2019-27.

20.

[Prophylactic oophorectomy among carriers of BRCA1/2 mutations--demographic and pathologic data].

Daum H, Sagi M, Pikarsky E, Pruss D, Hamburger T, Peretz T.

Harefuah. 2006 Jan;145(1):13-7, 79-80. Hebrew.

PMID:
16450717
21.

Application of embryonic lethal or other obvious phenotypes to characterize the clinical significance of genetic variants found in trans with known deleterious mutations.

Judkins T, Hendrickson BC, Deffenbaugh AM, Eliason K, Leclair B, Norton MJ, Ward BE, Pruss D, Scholl T.

Cancer Res. 2005 Nov 1;65(21):10096-103.

22.

Differential expression of protease activated receptor 1 (Par1) and pY397FAK in benign and malignant human ovarian tissue samples.

Grisaru-Granovsky S, Salah Z, Maoz M, Pruss D, Beller U, Bar-Shavit R.

Int J Cancer. 2005 Jan 20;113(3):372-8.

23.

Application of haplotype pair analysis for the identification of hemizygous loci.

Hendrickson BC, Pruss D, Lyon E, Scholl T.

J Med Genet. 2003 May;40(5):346-7.

24.

The pattern of expression of protease-activated receptors (PARs) during early trophoblast development.

Even-Ram SC, Grisaru-Granovsky S, Pruss D, Maoz M, Salah Z, Yong-Jun Y, Bar-Shavit R.

J Pathol. 2003 May;200(1):47-52.

PMID:
12692840
25.

Whole-genome shotgun assembly and analysis of the genome of Fugu rubripes.

Aparicio S, Chapman J, Stupka E, Putnam N, Chia JM, Dehal P, Christoffels A, Rash S, Hoon S, Smit A, Gelpke MD, Roach J, Oh T, Ho IY, Wong M, Detter C, Verhoef F, Predki P, Tay A, Lucas S, Richardson P, Smith SF, Clark MS, Edwards YJ, Doggett N, Zharkikh A, Tavtigian SV, Pruss D, Barnstead M, Evans C, Baden H, Powell J, Glusman G, Rowen L, Hood L, Tan YH, Elgar G, Hawkins T, Venkatesh B, Rokhsar D, Brenner S.

Science. 2002 Aug 23;297(5585):1301-10. Epub 2002 Jul 25.

26.

A draft sequence of the rice genome (Oryza sativa L. ssp. japonica).

Goff SA, Ricke D, Lan TH, Presting G, Wang R, Dunn M, Glazebrook J, Sessions A, Oeller P, Varma H, Hadley D, Hutchison D, Martin C, Katagiri F, Lange BM, Moughamer T, Xia Y, Budworth P, Zhong J, Miguel T, Paszkowski U, Zhang S, Colbert M, Sun WL, Chen L, Cooper B, Park S, Wood TC, Mao L, Quail P, Wing R, Dean R, Yu Y, Zharkikh A, Shen R, Sahasrabudhe S, Thomas A, Cannings R, Gutin A, Pruss D, Reid J, Tavtigian S, Mitchell J, Eldredge G, Scholl T, Miller RM, Bhatnagar S, Adey N, Rubano T, Tusneem N, Robinson R, Feldhaus J, Macalma T, Oliphant A, Briggs S.

Science. 2002 Apr 5;296(5565):92-100.

27.

Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals.

Frank TS, Deffenbaugh AM, Reid JE, Hulick M, Ward BE, Lingenfelter B, Gumpper KL, Scholl T, Tavtigian SV, Pruss DR, Critchfield GC.

J Clin Oncol. 2002 Mar 15;20(6):1480-90.

PMID:
11896095
28.

The BRCA2 genetic variant IVS7 + 2T-->G is a mutation.

Pyne MT, Brothman AR, Ward B, Pruss D, Hendrickson BC, Scholl T.

J Hum Genet. 2000;45(6):351-7.

PMID:
11185744
29.

A characterization of genetic variants in BRCA1 intron 8 identifies a mutation and a polymorphism.

Pyne MT, Pruss D, Ward BE, Scholl T.

Mutat Res. 1999 Aug;406(2-4):101-7.

PMID:
10479726
30.

Biochemical and genetic characterisation shows that the BRCA1 IVS20 insertion is a polymorphism.

Scholl T, Pyne MT, Ward B, Pruss D.

J Med Genet. 1999 Jul;36(7):571-2. No abstract available.

31.

DNA-protein cross-linking applications for chromatin studies in vitro and in vivo.

Pruss D, Gavin IM, Melnik S, Bavykin SG.

Methods Enzymol. 1999;304:516-33. No abstract available.

PMID:
10372379
32.

How does DNA methylation repress transcription?

Kass SU, Pruss D, Wolffe AP.

Trends Genet. 1997 Nov;13(11):444-9. Review.

PMID:
9385841
33.

BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing.

Shattuck-Eidens D, Oliphant A, McClure M, McBride C, Gupte J, Rubano T, Pruss D, Tavtigian SV, Teng DH, Adey N, Staebell M, Gumpper K, Lundstrom R, Hulick M, Kelly M, Holmen J, Lingenfelter B, Manley S, Fujimura F, Luce M, Ward B, Cannon-Albright L, Steele L, Offit K, Thomas A, et al.

JAMA. 1997 Oct 15;278(15):1242-50.

PMID:
9333265
34.

Activators and repressors: making use of chromatin to regulate transcription.

Wolffe AP, Wong J, Pruss D.

Genes Cells. 1997 May;2(5):291-302. Review.

35.

Chromatin studies by DNA-protein cross-linking.

Pruss D, Bavykin SG.

Methods. 1997 May;12(1):36-47.

PMID:
9169193
36.

Histone acetylation: chromatin in action.

Wade PA, Pruss D, Wolffe AP.

Trends Biochem Sci. 1997 Apr;22(4):128-32. Review.

PMID:
9149532
37.

An asymmetric model for the nucleosome: a binding site for linker histones inside the DNA gyres.

Pruss D, Bartholomew B, Persinger J, Hayes J, Arents G, Moudrianakis EN, Wolffe AP.

Science. 1996 Oct 25;274(5287):614-7.

PMID:
8849453
38.
39.
40.

Targeting chromatin disruption: Transcription regulators that acetylate histones.

Wolffe AP, Pruss D.

Cell. 1996 Mar 22;84(6):817-9. Review. No abstract available.

41.

Hanging on to histones. Chromatin.

Wolffe AP, Pruss D.

Curr Biol. 1996 Mar 1;6(3):234-7. Review.

42.

Deviant nucleosomes: the functional specialization of chromatin.

Wolffe AP, Pruss D.

Trends Genet. 1996 Feb;12(2):58-62. Review.

PMID:
8851972
43.

Nucleosomal anatomy--where are the histones?

Pruss D, Hayes JJ, Wolffe AP.

Bioessays. 1995 Feb;17(2):161-70. Review.

PMID:
7748166
44.

The influence of DNA and nucleosome structure on integration events directed by HIV integrase.

Pruss D, Reeves R, Bushman FD, Wolffe AP.

J Biol Chem. 1994 Oct 7;269(40):25031-41.

45.

Contacts of the globular domain of histone H5 and core histones with DNA in a "chromatosome".

Hayes JJ, Pruss D, Wolffe AP.

Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7817-21.

46.
47.

Histone-DNA contacts in a nucleosome core containing a Xenopus 5S rRNA gene.

Pruss D, Wolffe AP.

Biochemistry. 1993 Jul 13;32(27):6810-4.

PMID:
8334114
48.

A positive role for histone acetylation in transcription factor access to nucleosomal DNA.

Lee DY, Hayes JJ, Pruss D, Wolffe AP.

Cell. 1993 Jan 15;72(1):73-84.

PMID:
8422685
49.

Transcription factor access to DNA in the nucleosome.

Wolffe AP, Almouzni G, Ura K, Pruss D, Hayes JJ.

Cold Spring Harb Symp Quant Biol. 1993;58:225-35. No abstract available.

PMID:
7956033
50.

Chromatin superstructure-dependent crosslinking with DNA of the histone H5 residues Thr1, His25 and His62.

Mirzabekov AD, Pruss DV, Ebralidse KK.

J Mol Biol. 1990 Jan 20;211(2):479-91.

PMID:
2106584

Supplemental Content

Support Center